Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track IRWD with free AI briefings, catalyst countdowns, and dilution alerts.

IRWD · IRONWOOD PHARMACEUTICALS INC

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$79.1M Cash on Hand

CF+ Cash Runway

Follow IRWD by email Get an email when IRWD pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about IRWD, unsubscribe in one click. Privacy

🧪 Trial & FDA Catalysts

Sep 2025 · Phase 3 · Results Expected · A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in
Registry primary completion date, not a results date
Jun 2025 · Phase 2 · Results Expected · A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants
Registry primary completion date, not a results date
Jun 2025 · Phase 3 · Results Expected · Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
Registry primary completion date, not a results date
May 2024 · Phase 3 · Results Expected · Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irri
Registry primary completion date, not a results date
Jun 2022 · Phase 1 · Results Expected · A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects
Registry primary completion date, not a results date
Mar 2022 · Phase 1 · Results Expected · A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers
Registry primary completion date, not a results date

📊 Drug Pipeline

Drug	Indication	Most advanced trial	Status
Lesinurad FDA approved Dec 2015 · Zurampic (discontinued)	Gout	Phase 4 · NCT03226899	Terminated
Therapeutic Corticosteroid	Gout	Phase 4 · NCT03226899	Terminated
Standard-dose PPIs QD	Gastroesophageal Reflux Disease (GERD)	Phase 3 · NCT03561090	Terminated
Functional Constipation (FC) participant	Irritable Bowel Syndrome With Constipation	Phase 3 · NCT04166058	Completed
Irritable Bowel Syndrome with Constipati	Irritable Bowel Syndrome With Constipation	Phase 3 · NCT04166058	Completed
IW-3718	Gastroesophageal Reflux Disease (GERD)	Phase 3 · NCT03561090	Terminated
Proton Pump Inhibitor	Gastroesophageal Reflux Disease	Phase 2 · NCT02637557	Completed
MD-7246	Irritable Bowel Syndrome With Diarrhea (IBS-D)	Phase 2 · NCT03931785	Completed
Linaclotide Acetate	Constipation	Phase 2 · NCT00306748	Completed
MD-0727	Hypercholesterolemia	Phase 2 · NCT00404001	Completed
IW-6118	Healthy	Phase 2 · NCT01107236	Completed
IW-3300 rectal foam	Interstitial Cystitis	Phase 2 · NCT05740007	Terminated
IW-9179	Diabetic Gastroparesis	Phase 2 · NCT02289846	Completed
Microgestin®	Healthy Volunteers	Phase 1 · NCT03856970	Completed
Levothyroxine	Healthy Volunteers	Phase 1 · NCT03856970	Completed
IW-3300	Healthy Volunteers	Phase 1 · NCT05362695	Completed

Also used in these trials (approved or third-party drugs, not IRWD's own candidates): Allopurinol, Linaclotide, Colchicine, Naproxen Sodium 220Mg, Glyburide, Digoxin.

Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it

💰 Cash Runway & Dilution Risk

IRWD holds $79.1M in cash and short-term investments (as of Jun 30, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

No operating cash burn in latest filings

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when IRWD files for a raise →

Get the full IRWD picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for IRWD and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z